These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7776460)

  • 1. Incidence of penile pain after injection of a new formulation of prostaglandin E1.
    Chen J; Godschalk MF; Katz PG; Mulligan T
    J Urol; 1995 Jul; 154(1):77-9. PubMed ID: 7776460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
    Chen RN; Lakin MM; Montague DK; Ausmundson S
    J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow injection of prostaglandin E1 decreases associated penile pain.
    Gheorghiu D; Godschalk M; Gheorghiu S; Mulligan T
    Urology; 1996 Jun; 47(6):903-4. PubMed ID: 8677586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of a new formulation of prostaglandin E1 as treatment for erectile failure.
    Godschalk M; Gheorghiu D; Chen J; Katz PG; Mulligan T
    J Urol; 1996 Mar; 155(3):915-7. PubMed ID: 8583606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction.
    El-Sakka AI
    Int J Impot Res; 2006; 18(2):180-5. PubMed ID: 16163370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction.
    Chen J; Godschalk M; Katz PG; Mulligan T
    J Urol; 1995 Jan; 153(1):80-1. PubMed ID: 7966797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Office treatment: intracavernous injections of prostaglandin E1 (PG E1) and improvement of spontaneous erections.
    Beretta G; Marzotto M; Zanollo A; Re B
    Acta Eur Fertil; 1991; 22(4):221-3. PubMed ID: 1844326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
    Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction.
    Schramek P; Plas EG; Hübner WA; Pflüger H
    J Urol; 1994 Oct; 152(4):1108-10. PubMed ID: 8072075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cavernous auto-injection therapy with prostaglandin E1.
    Nisén H
    Ann Chir Gynaecol Suppl; 1993; 206():69-73. PubMed ID: 8291874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].
    Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S
    Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkalization does not alleviate penile pain induced by intracavernous injection of prostaglandin E1.
    Godschalk M; Gheorghiu D; Katz PG; Mulligan T
    J Urol; 1996 Sep; 156(3):999-1000. PubMed ID: 8709384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction.
    Cawello W; Schweer H; Dietrich B; Seyberth HW; Albrecht D; Fox A; Hohmuth H
    J Urol; 1997 Oct; 158(4):1403-7. PubMed ID: 9302131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
    Valdevenito R; Melman A
    Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological erection program using prostaglandin E1.
    Gerber GS; Levine LA
    J Urol; 1991 Sep; 146(3):786-9. PubMed ID: 1875494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a needle-free high-pressure injection system with needle-tipped injection of intracavernosal alprostadil for erectile dysfunction.
    Harding LM; Adeniyi A; Everson R; Barker S; Ralph DJ; Baranowski AP
    Int J Impot Res; 2002 Dec; 14(6):498-501. PubMed ID: 12494285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.